PishPosh, Inc. (BABY) earnings
Quarterly and annual BABY reports and results, each read against the price at its own news timestamp. Back to the BABY overview →
6 measured BABY earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K/A PishPosh, Inc. For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q PishPosh, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q PishPosh, Inc. For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q PishPosh, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K PishPosh, Inc. For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q PishPosh, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | — |
Keep exploring
More BABY: analyst actions → · SEC filings → · BABY overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Pluristem Therapeutics, Inc. (PSTI) | 704 | -0.23% | 40% |
| Synthetic Biologics, Inc. (SYN) | 703 | -0.34% | 41% |
| Insmed Incorporated (INSM) | 701 | -0.08% | 45% |
| Revance Therapeutics, Inc. (RVNC) | 701 | 0.00% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.